Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 15.27 Million AUD | -31.74% |
| 2023 | 22.37 Million AUD | -35.85% |
| 2022 | 34.87 Million AUD | -4.45% |
| 2021 | 36.5 Million AUD | 36504760.0% |
| 2020 | 100.00 AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 15.27 Million AUD | -31.74% |
| 2024 Q2 | 26.68 Million AUD | 0.0% |
| 2024 Q1 | 26.68 Million AUD | 19.27% |
| 2024 Q4 | 15.27 Million AUD | 0.0% |
| 2023 FY | 22.37 Million AUD | -35.85% |
| 2023 Q4 | 22.37 Million AUD | 0.0% |
| 2023 Q1 | 22.51 Million AUD | -35.44% |
| 2023 Q3 | 22.37 Million AUD | -0.64% |
| 2023 Q2 | 22.51 Million AUD | 0.0% |
| 2022 Q3 | 34.87 Million AUD | 24.18% |
| 2022 Q1 | 28.08 Million AUD | -23.06% |
| 2022 Q2 | 28.08 Million AUD | 0.0% |
| 2022 FY | 34.87 Million AUD | -4.45% |
| 2022 Q4 | 34.87 Million AUD | 0.0% |
| 2021 Q1 | 13.79 Million AUD | 0.0% |
| 2021 FY | 36.5 Million AUD | 36504760.0% |
| 2021 Q3 | 36.5 Million AUD | 164.68% |
| 2021 Q4 | 36.5 Million AUD | 0.0% |
| 2021 Q2 | 13.79 Million AUD | 0.0% |
| 2020 FY | 100.00 AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3896.356% |
| CSL Limited | 38.02 Billion USD | 99.96% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 60.684% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -111.547% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -19903.083% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -44.714% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 88.27% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -21005.72% |
| Mesoblast Limited | 667.9 Million USD | 97.713% |
| Marizyme, Inc. | 22.01 Million USD | 30.624% |
| Genus plc | 1.02 Billion USD | 98.516% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1024.388% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -2960.513% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2335.91% |
| ContraFect Corporation | 20.67 Million USD | 26.142% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3812.522% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 31.33 Million USD | 51.257% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -268.381% |
| MultiCell Technologies, Inc. | 126.22 USD | -12100323.071% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1525.341% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 88.115% |
| EV Biologics, Inc. | 431.71 Thousand USD | -3437.794% |
| Q BioMed Inc. | 3.51 Million USD | -334.45% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 56.584% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -5745.579% |
| Biomind Labs Inc. | 73.81 Thousand USD | -20590.004% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 49.115% |
| Skye Bioscience, Inc. | 11.94 Million USD | -27.911% |
| SQZ Biotechnologies Company | 107.18 Million USD | 85.751% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -456.129% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -679.963% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -966.537% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2121.595% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1881.869% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 96.7% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -361.005% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -486.708% |
| GB Sciences, Inc. | 103.44 Thousand USD | -14664.945% |
| Alpha Cognition Inc. | 2.45 Million USD | -522.842% |
| argenx SE | 4.54 Billion USD | 99.664% |
| HST Global, Inc. | 1526.00 USD | -1000761.992% |
| Halberd Corporation | 10.13 Thousand USD | -150656.628% |
| Enzolytics Inc. | 361.7 Million USD | 95.777% |
| Resverlogix Corp. | 8.11 Million USD | -88.209% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -713.319% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 45.344% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 96.578% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 67.982% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -954.162% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -2287.714% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -66943.387% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -70.666% |
| AVAX Technologies, Inc. | 7.37 Million USD | -107.033% |
| ONE Bio Corp. | 70.08 Million USD | 78.208% |
| Zenith Capital Corp. | 7410.00 USD | -206015.439% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.549% |
| Ember Therapeutics, Inc. | 184.00 USD | -8300527.174% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -4646.075% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -5743.633% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1545.883% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1445.917% |
| Agentix Corp. | 261.39 Thousand USD | -5743.007% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.3 Million USD | -562.874% |
| Helix BioMedix, Inc. | 3.02 Million USD | -404.883% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 71.019% |
| BioStem Technologies, Inc. | 14.56 Million USD | -4.896% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -26650.892% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -661075.498% |
| LadRx Corporation | 2.3 Million USD | -561.782% |
| Cell Source, Inc. | 195.17 Thousand USD | -7725.524% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -3078.219% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4219.123% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4219.123% |
| NovAccess Global Inc. | 62.24 Thousand USD | -24435.975% |
| Affymax, Inc. | 7.44 Million USD | -105.202% |
| Itoco Inc. | 1.4 Million USD | -990.883% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -15866.583% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -14308.636% |
| CytoDyn Inc. | 11.13 Million USD | -37.151% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -10582.619% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -85320.324% |
| Qrons Inc. | 420.00 USD | -3636365.238% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3862.206% |
| SYBLEU INC | 330.46 Thousand USD | -4521.674% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2666.274% |
| Rebus Holdings, Inc. | 5000.00 USD | -305363.08% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3630.418% |
| Mobile Lads Corp. | 52.00 USD | -29371350.0% |
| International Stem Cell Corporation | 5.39 Million USD | -183.361% |
| Bioxytran, Inc. | 137.63 Thousand USD | -10996.611% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -1.809% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 7.877% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -19233.106% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1666.342% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -103.182% |
| Neutra Corp. | 2851.00 USD | -535612.171% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 52.869% |
| PureTech Health plc | 693.97 Million USD | 97.799% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -89.233% |
| IXICO plc | 15.84 Million USD | 3.602% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -84.414% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 85.218% |
| CSL Limited | 38.02 Billion USD | 99.96% |
| Cellectis S.A. | 333.99 Million USD | 95.427% |